Fludrocortisone
| |
| Fludrocortisone
| |
| Systematic (IUPAC) name | |
| 9-fluoro-11,17-dihydroxy-17- (2-hydroxyacetyl)- 10,13-dimethyl- 1,2,6,7,8,9,10,11,12, 13,14,15,16,17- tetradecahydrocyclopenta[a]phenanthren-3-one | |
| Identifiers | |
| CAS number | |
| ATC code | H02 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C21H29FO5 |
| Mol. mass | 380.45 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | High |
| Metabolism | Hepatic |
| Half life | 3.5 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C |
| Legal status | |
| Routes | oral |
|
WikiDoc Resources for Fludrocortisone | |
|
Articles | |
|---|---|
|
Most recent articles on Fludrocortisone Most cited articles on Fludrocortisone | |
|
Media | |
|
Powerpoint slides on Fludrocortisone | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Fludrocortisone at Clinical Trials.gov Trial results on Fludrocortisone Clinical Trials on Fludrocortisone at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Fludrocortisone NICE Guidance on Fludrocortisone
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Fludrocortisone Discussion groups on Fludrocortisone Patient Handouts on Fludrocortisone Directions to Hospitals Treating Fludrocortisone Risk calculators and risk factors for Fludrocortisone
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Fludrocortisone | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Fludrocortisone is a synthetic corticosteroid with moderate glucocorticoid potency and much greater mineralocorticoid potency. It is used primarily to replace the missing hormone aldosterone in various forms of adrenal insufficiency such as Addison's disease and the classic salt wasting (21-hydroxylase deficiency) form of congenital adrenal hyperplasia. It is occasionally used to treat orthostatic hypotension as well.
The brand name in the U.S. is Florinef. It is available in 0.1 mg tablets. Typical daily doses for mineralocorticoid replacement are between 0.05 mg - 0.2 mg. Renin plasma, sodium, and potassium is checked through blood tests in order to verify that the correct dosage is reached.
Chemically, its structure is identical to cortisone except for the substitution of F in place of one hydrogen. F is a good bioisostere for hydrogen because it is similar in size. The major difference is in its electronegativity.
Corticosteroids for systemic use (H02) | |
|---|---|
| Mineralocorticoids | Aldosterone - Fludrocortisone - Desoxycortone |
| Glucocorticoids | Betamethasone - Dexamethasone - Fluocortolone - Methylprednisolone - Paramethasone - Prednisolone - Prednisone - Triamcinolone - Hydrocortisone - Cortisone - Prednylidene - Rimexolone - Deflazacort - Cloprednol - Meprednisone - Cortivazol |
| Anticorticosteroids | Trilostane |
Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs
Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link HereThere is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
